What is the EVERY?
The EVERY Company, based in San Francisco, California, is at the forefront of biotechnology, specializing in the creation of proteins and other products traditionally derived from animals. By leveraging innovative scientific approaches, the company aims to provide sustainable alternatives to conventional animal agriculture, addressing growing market demand for ethical and environmentally conscious food production. The company's focus on developing animal-free proteins positions it as a key player in the rapidly expanding alternative protein market.
How much funding has the EVERY raised?
the EVERY has raised a total of $315.1M across 8 funding rounds:
Angel/Seed
$1.7M
Angel/Seed
$20M
Debt
$350K
Multiple Rounds
$238M
Series D
$55M
Angel/Seed (2015): $1.7M, investors not publicly disclosed
Angel/Seed (2019): $20M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Debt (2021): $8M featuring Horizon Technology Finance Management LLC
Series A (2021): $15M, investors not publicly disclosed
Series B (2021): $40M, investors not publicly disclosed
Series C (2021): $175M led by Mcwin and RAGING CAPITAL MANAGEMENT
Series D (2025): $55M supported by McWin Capital Partners, TO VC (to.vc, Bloom8, and Grosvenor
Key Investors in the EVERY
McWin Capital Partners
McWin Capital Partners is a private investment firm that specializes in partnering with founders and CEOs to drive sustainable disruption in the food service and food technology sectors. The company focuses on growth-stage investment opportunities and aims to transform the food ecosystem through strategic investments in innovative companies.
TO VC
TO VC is an early-stage venture capital fund that invests in innovative founders who are transforming energy production, food growth, infrastructure development, and climate change adaptation. The firm focuses on supporting visionary teams that aim to reshape the global economy.
Bloom8
Bloom8 focuses on the FoodTech sector, investing in visionary founders who utilize disruptive technologies to improve food production and consumption. With a commitment to enhancing the global food system, they aim to accelerate the development of sustainable innovations that benefit both people and the planet.
What's next for the EVERY?
With substantial backing, The EVERY Company is poised for accelerated growth and further innovation in its product development pipeline. The recent major strategic investment suggests a focus on scaling production capabilities, expanding market reach, and potentially forging new partnerships within the food technology ecosystem. This capital infusion will likely enable the company to further its mission of transforming the food industry through sustainable, animal-free solutions, solidifying its position as a leader in the alternative protein space.
See full the EVERY company page
